Staggered Treatment Activation Protocol
RCTClinical Trial
Rolling participant recruitment introduces varying baseline exposure times, making fixed-date treatment rollouts problematic for measuring pre-treatment behavior. Staggering treatment activation relative to individual enrollment dates ensures adequate baseline observation windows for every participant.
Picture this
Instead of flipping a switch on the same calendar day for everyone regardless of when they joined a study, you wait until each individual participant has completed a set probationary period (e.g., 6 to 9 weeks) before activating their new feature access.
What the evidence says
Established a uniform 5-week pre-treatment baseline window per respondent, enabling precise subsample categorization between low and high pre-treatment remitters.
- Who was studied
- 2,213 treatment-assigned migrant workers in Dubai and Sharjah, UAE.
- How
- Individual-level staggered intervention activation between follow-up weeks 6 and 9 following a mandatory 4-week compliance screening window.
What to do
Stagger experimental feature activation relative to individual participant onboarding dates to establish uniform baseline observation periods.
From the source
"Those assigned to the treatment group were randomly selected to receive the intervention starting week 6/7/8/9. All respondents, regardless of treatment assignment, completed the study after week 30..."
A Field Experiment among Filipino Migrant Workers in the UAE